Vance Thompson Vision
Clinical trials sponsored by Vance Thompson Vision, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can four eye scanners detect how miebo stabilizes tears? Results expected Sep 2026 (estimated)
- Can a simple eye drop stop dry eye after LASIK? Results expected Nov 2026 (estimated)
- New eye drops aim to soothe dryness after laser eye surgery Results expected Dec 2026 (estimated)
- Can a new lens make glasses obsolete after cataract surgery? Results expected Jul 2027 (estimated)
- LASIK gets a precision upgrade to sharpen night vision Results expected Sep 2027 (estimated)
-
Can a new lens make glasses obsolete after cataract surgery?
Disease control Not yet recruitingThis trial tests the TECNIS PureSee, an extended depth of focus lens implanted during cataract surgery, in 50 adults with cataracts in both eyes. The goal is to see how well the lens restores vision at distance, intermediate, and near ranges, and whether it allows people to go wi…
Phase 4 • Sponsor: Vance Thompson Vision • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Laser procedure could offer new hope for pseudoexfoliation glaucoma patients
Disease control Not yet recruitingThis study tests a non-invasive laser procedure called direct selective laser trabeculoplasty (DSLT) in 40 adults with pseudoexfoliation glaucoma. The goal is to see if the laser can safely lower eye pressure by at least 20% at 6 and 12 months. Participants will have their eye pr…
Sponsor: Vance Thompson Vision • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC